TAMPA, FL / ACCESS Newswire / November 20, 2025 / (“Wellgistics”) (NASDAQ:WGRX), a health information technology leader at the nexus of serialization of healthcare technology infrastructure into the ...

Eli Lilly on Friday crossed the $1 trillion market-cap threshold, becoming the first drugmaker to ever reach that milestone.

New research is shedding light on how weight-loss and diabetes medications like Ozempic, Wegovy, and Mounjaro affect not only ...

We asked doctors who prescribe GLP-1 medications to break down this trend and explain whether it’s worth it to consider ...

A growing number of people are searching for weight loss options that feel manageable in daily life. Many of the current ...

GLP-1 RAs are associated with a 62% reduction in 5-year mortality in colon cancer patients, especially those with high obesity. The study's findings remained significant after adjusting for ...

New GLP-1 weight-loss drugs may preserve muscle, protect skin, and reduce the risk of "Ozempic face." Experts explain what ...

The demand for weight-loss drugs like Ozempic and Zepbound is higher than ever, so much so that drugmakers Novo Nordisk and ...

By 2030, households with GLP-1 users are projected to represent 35% of all food and beverage units sold, the consumer ...

A massive real-world study comparing tirzepatide and semaglutide reveals both drugs deliver strong, early cardiovascular ...

Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) use was significantly associated with a reduced odds of five-year mortality, but this protective effect was found to be statistically significant ...

NBC News' Anne Thompson joins "Here's the Scoop" co-host Yasmin Vossoughian to talk about why some people are microdosing GLP ...